What Do Biotech IPOs Say About the Market Today?
2015 started out strong for biotech IPOs, but in recent weeks there's been a slowdown.
October 22nd, 2015
Trans-Pacific Partnership Could Further Depress Biotech Stocks
The NASDAQ Biotechnology Index is falling, following media criticism about the industry's pricing practises. The Trans-Pacific...
October 7th, 2015
The Basics of Biotechnology ETF Funds
Everything that investors need to know about decreasing risk through diversification in the biotech sector.
September 24th, 2015
HedgePath Pharmaceuticals Looking to the Future with New Clinical...
The company's announcement points to a larger trend towards biotech innovation in the San Diego area.
August 23rd, 2015
Apricus Biosciences Seeking Global Partner Following FDA Approval of...
Apricus hopes that the FDA's approval of Addyi, a drug from Sprout Pharmaceuticals, will offer a...
August 19th, 2015
Pfenex Signs $143.3-million, Five-year Deal with US Department of...
The contract, valued at approximately $143.5 million, will support the development of Pfenex's mutant recombinant protective...
August 18th, 2015
Global Blood Therapeutics Debuts with Successful $120-million IPO
Global Blood Therapeutics began trading on the NASDAQ on Wednesday. The company raised $120 million in...
August 12th, 2015